Delivery Order SPE2DB22D9143-SPE2DB25FZC46
Award Date 7/21/25
Potential Completion Date 7/22/25
Potential Value $4.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This delivery order, awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., is for the delivery of 120 capsules of XTANDI 40 MG CAPSULE. The potential value of this firm fixed price order is $4,311.35. Performance will occur in Park Ridge, Illinois with an anticipated completion date of October 6, 2023. No set-aside designation was used for this award placed under an unidentified medical supply vehicle. The Defense Logistics Agency Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. under an indefinite-delivery/indefinite-quantity contract vehicle. The order is for 120 capsules of XTANDI 40 MG CAPSULE at a firm fixed price of $12,934.05. Performance will take place in Park Ridge, Illinois with completion by March 23, 2023. No set-aside provision was applied to this order. The DLA supports military readiness by procuring and providing medical supplies and pharmaceuticals to armed...
- This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the provision of 120 capsules of XTANDI 40 MG CAPSULE. The order has a potential value of $77,604.30 under a firm fixed price arrangement. Performance will occur in Park Ridge, Illinois with an anticipated completion date of October 16, 2023. No set-aside designation was applied to this award made in support of the Defense Logistics Agency's pharmaceutical procurement and distribution programs.
- This delivery order for $4,311.35, awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., is for 120 capsules of XTANDI 40 MG CAPSULE to be delivered by October 12, 2023. The firm fixed price contract has no set-aside designation. XTANDI is used to treat men with prostate cancer and this order will support the Defense Logistics Agency's medical supply needs. DMS Pharmaceutical Group Inc. will deliver the products from their facility in Park Ridge,...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at $17,245.40 to DMS Pharmaceutical Group Inc. The order is for 120 capsules of XTANDI 40 MG CAPSULE to be delivered to a location in Park Ridge, Illinois. XTANDI is used to treat men with prostate cancer. The period of performance for this order is from August 29, 2023 through August 30, 2023. No subcontractors or set aside designations were...
- This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of 120 capsules of XTANDI 40 MG CAPSULE. The potential value of this firm fixed price order is $12,934.05. Performance will occur in Park Ridge, Illinois, with delivery required by May 30, 2023. No set-aside designation was used for this procurement. As the Defense Logistics Agency is responsible for worldwide logistics support for the U.S. military, this order is likely intended to...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc. valued at approximately seventeen thousand two hundred forty-five dollars and forty cents ($17,245.40) to supply one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE. Performance will take place in Park Ridge, Illinois and is required to be completed by May 2, 2023. The order was awarded on May 1, 2023 under an existing contract vehicle and no set-aside designation was applied. XTANDI...
- This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the provision of 120 capsules of XTANDI 40 MG CAPSULE at a firm fixed price of $8,643.02. The place of performance is Park Ridge, Illinois and all items are to be delivered by November 10, 2022. No set-aside designation was used for this procurement. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement, distribution and supply chain management for the...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. valued at seventeen thousand two hundred forty-five dollars and forty cents ($17,245.40) to supply one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE. Performance will take place in Park Ridge, Illinois with completion by May 5, 2023. The firm fixed price contract was awarded on May 4, 2023 without a set-aside designation. As the DLA supports military treatment facilities, this order for the prostate...
- This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of 120 capsules of XTANDI 40 MG CAPSULE at a firm fixed price of $12,964.50. The place of performance is Park Ridge, Illinois and all items are to be delivered by December 12, 2022. No set-aside designation was used for this order placed under an existing DLA pharmaceutical supply contract vehicle. As the Defense Logistics Agency's primary role includes procuring, managing and...
- SPE2DB22D9143Indefinite Delivery Contract
- SPE2DB22D9143-SPE2DB25FZC46Delivery Order
4568849834 ! XTANDI 40 MG CAPSULE 120S
Posted 7/21/25
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 7/21/25 |